Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The implant is infused with a drug meant to keep the immune cells that the virus targets in a resting state.
An analysis of a previous study of a tenofovir-based vaginal gel found that women with vaginal inflammation were less protected.
A one-month version of the ring is currently up for regulatory approval.
Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.
Here’s how you can take action to support rectal microbicide research.
An anti-HIV vaginal microbicide gel lowered risk among women with a healthier dominant bacterial population.
Researchers have made progress in developing a microbicide enema that protects against contracting HIV through anal sex.
Scientists have made progress developing such a microbicide, with promising results in tests among monkeys.
All of the big HIV science revelations from the Conference on Retroviruses and Opportunistic Infections, including the PrEP failure case.
A trial of a Viread (tenofovir)-containing vaginal gel to protect against HIV has failed because the South African women participants used it...
The NIH has awarded a $14.7 million grant to a team developing a microbicide with an HIV-fighting protein they will cultivate in tobacco plant...
An Isentress-containing microbicide gel prevents vaginal transmission of the simian cousin of HIV, SIV, when used as a post-exposure...
After many years of failures, recent studies have moved researchers closer to a form of HIV prevention that women can use discreetly.
A new potential microbicide element may be fooling HIV.
A new potential microbicide element tricks HIV into expelling its DNA before latching onto a human cell, thus prompting a benign death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.